SANTA CLARA, CA, ValGenesis, the global leader in digital validation lifecycle management and backed by investment funds managed by Morgan Stanley Expansion Capital.
ValGenesis, the global leader in digital validation lifecycle management and backed by investment funds managed by Morgan Stanley Expansion Capital, today announced it has secured strategic financing of up to $16 million from the Innovation Banking Group at Bridge BankĀ®, a division of Western Alliance Bank, Member FDIC. The Innovation Banking Group specializes in serving high-growth life sciences, technology, and innovation companies.
ValGenesis is the creator of ValGenesis Smart GxP, the life sciences industry's first fully integrated, cloud-based, AI-enabled platform for end-to-end product lifecycle digitalization. Trusted by 30 of the world's top 50 life sciences companies, our platform unifies intelligent, risk-based validation and process automation in a connected ecosystem-streamlining operations, driving compliance, and reducing risk. Purpose-built for life sciences, ValGenesis empowers global organizations to improve quality of life by accelerating the delivery of consistent, safer products.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
